Company Encyclopedia
View More
name
UNI MEDICAL
02666.HK
Genertec Universal Medical Group Company Limited, together with its subsidiaries, provides financing, advisory, and medical services in the People’s Republic of China. It operates through two segments, Finance Business and Healthcare Business. The Finance Business segment offers direct finance leasing; sale and leaseback; accounts receivable factoring; operating leases; and advisory services. Its Healthcare Business segment includes medical and healthcare services; hospital operations; import, export, and trading of medical-related goods; equipment life cycle management; medical digitalization services; and intelligent medical health and elder care.
52.63 B
02666.HKMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
C
Health Care ServicesIndustry
Industry Ranking3/28
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE11.21%B
    • Profit Margin15.23%A
    • Gross Margin33.64%C
  • Growth ScoreC
    • Revenue YoY9.08%B
    • Net Profit YoY3.14%C
    • Total Assets YoY3.98%C
    • Net Assets YoY4.28%C
  • Cash ScoreB
    • Cash Flow Margin677.44%C
    • OCF YoY9.08%B
  • Operating ScoreD
    • Turnover0.17D
  • Debt ScoreD
    • Gearing Ratio73.38%D

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    UNI MEDICAL issues up to 200 million yuan in medium-term notes

    According to a report from Economic Information Daily on the 6th, UNI MEDICAL announced that its subsidiary, General Universal International Financing Leasing (Tianjin) Co., Ltd., has decided to issue domestic medium-term notes in the first phase of 2025 with a total principal amount of up to RMB 200 million to institutional investors within China. The related net proceeds will be used by the issuer to repay maturing debts. (rh)

    etnet·
    HK
    02666
    0.00%
    etnet·
    HK
    02666
    0.00%

    Pacific Securities: Maintain "Buy" rating on UNI MEDICAL with a target price of HKD 7.97

    Pacific Securities maintains a "Buy" rating on UNI MEDICAL, with a target price of HKD 7.97. It is expected that the operating revenues for 2025-2027 will be 14.723 billion, 15.343 billion, and 16.254 billion yuan, respectively, with net profits attributable to the parent company of 2.118 billion, 2.228 billion, and 2.366 billion yuan. The healthcare business has become the core growth engine, with revenue of 4.964 billion yuan in the first half of 2025, a year-on-year increase of 27.7%. The financial business is stable, with sufficient risk resistance capability

    Zhitong·
    HK
    02666
    0.00%
    Zhitong·
    HK
    02666
    0.00%

    In the first three quarters, UNI MEDICAL's profit attributable to common shareholders increased by approximately 4.2% year-on-year

    UNI MEDICAL announced that for the first three quarters of 2025, the group's revenue increased by approximately 12.8% year-on-year, with profit for the period increasing by approximately 7.6% year-on-year, and profit attributable to ordinary shareholders increasing by approximately 4.2% year-on-year. The group actively responds to the impact of policy changes such as medical insurance payment reform, enhances medical service capabilities, optimizes business structure, strengthens cost control, and promotes the sustainable development of medical institutions. At the same time, the financial business is undergoing transformation and innovation, accelerating the transition in multiple directions

    Zhitong·
    HK
    02666
    0.00%
    Zhitong·
    HK
    02666
    0.00%

    In the first three quarters, UNI MEDICAL's revenue increased by 12.8% year-on-year, and net profit rose by 4.2%

    UNI MEDICAL's revenue for the nine months ending September increased by 12.8% year-on-year, with profit rising by 7.6% and profit attributable to common shareholders increasing by 4.2%. The group's medical institutions operated well, with outpatient and emergency visits increasing by 3.4% year-on-year, discharges rising by 1.7%, and the average length of stay decreasing to 9.1 days. Revenue from medical services accounted for 36.5%, an increase of 2.3 percentage points, while the cost of medical supplies as a percentage of revenue decreased to 43%

    AASTOCKS·
    HK
    02666
    0.00%
    AASTOCKS·
    HK
    02666
    0.00%

    UNI MEDICAL: UNI Leasing has completed the issuance of 300 million yuan of renewable corporate bonds

    UNI MEDICAL announced that its wholly-owned subsidiary, China Global Leasing Co., Ltd., has successfully issued RMB 300 million of perpetual corporate bonds in China. The bonds were issued on October 28, 2025, with a base term of 1 year and a fixed interest rate of 2.05%. The issuance price is RMB 100 per bond, equal to 100% of the face value

    Zhitong·
    HK
    02666
    0.00%
    Zhitong·
    HK
    02666
    0.00%
    © 2025 Longbridge｜Disclaimer